The Smart(est) Choice for Dual Antiplatelet Therapy Is a Patient-Directed One

JAMA Cardiol. 2022 Nov 1;7(11):1109. doi: 10.1001/jamacardio.2022.3219.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Clopidogrel
  • Dual Anti-Platelet Therapy
  • Humans
  • Platelet Aggregation Inhibitors* / therapeutic use
  • Ticlopidine*

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine